WOONSOCKET, R.I. — CVS Caremark’s board of directors has approved a new share repurchase program for up to $4 billion of the company's outstanding common stock.
The share repurchase authorization, which is effective immediately, enables the pharmacy retailer to affect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.
